Impressão Tridimensional: uma nova abordagem na área farmacêutica
DOI:
https://doi.org/10.61411/rsc202482917Palavras-chave:
Medicamentos personalizados, Impressão 3D, Modelo tridimensionalResumo
A abordagem terapêutica personalizada, que busca fornecer tratamentos individualizados para pacientes, surgiu como um novo modelo no tratamento de doenças, em contraposição a terapias genéricas. Tratamentos direcionados ao paciente são possíveis graças aos avanços tecnológicos na produção e administração de medicamentos. Este estudo realiza uma revisão sistemática sobre o estado da arte na manufatura aditiva (impressão 3D). A aprovação do SPRITAM® (levetiracetam) pelo FDA em 2015 como o primeiro medicamento aprovado para manufatura via impressão 3D trouxe um aumento dos estudos mostrando as aplicabilidades da personalização de medicamentos feitos por essa técnica, mas também trazendo as preocupações quanto a este processo. Este estudo aborda as possibilidades e desafios das diferentes técnicas na personalização de medicamentos, e o impacto na profissão do farmacêutico.
Referências
Abrahams, E., Ginsburg, G. S., & Silver, M. (2005). The personalized medicine coalition: goals and strategies. American Journal of Pharmacogenomics, 5, 345-355. https://doi.org/10.2165/00129785-200505060-00002. DOI: https://doi.org/10.2165/00129785-200505060-00002
Alhnan, M. A., Okwuosa, T. C., Sadia, M., Wan, K. W., Ahmed, W., & Arafat, B. (2016). Emergence of 3D printed dosage forms: opportunities and challenges. Pharmaceutical research, 33, 1817-1832. https://doi.org/10.1007/s11095-016-1933-1. DOI: https://doi.org/10.1007/s11095-016-1933-1
Anwar-Fadzil, A. F. B., Yuan, Y., Wang, L., Kochhar, J. S., Kachouie, N. N., & Kang, L. (2022). Recent progress in three-dimensionally-printed dosage forms from a pharmacist perspective. Journal of Pharmacy and Pharmacology, 74(10), 1367-1390. https://doi.org/10.1093/jpp/rgab168. DOI: https://doi.org/10.1093/jpp/rgab168
Barrett, M. (2008). Intellectual property. Wolters Kluwer.
Basit, A. W., & Trenfield, S. J. (2022). 3D printing of pharmaceuticals and the role of pharmacy. Pharm. J, 308, 7959. https://doi.org/10.1016/j.ijpx.2022.100120. DOI: https://doi.org/10.1016/j.ijpx.2022.100120
Beg, S., Almalki, W. H., Malik, A., Farhan, M., Aatif, M., Rahman, Z., ... & Rahman, M. (2020). 3D printing for drug delivery and biomedical applications. Drug Discovery Today, 25(9), 1668-1681. https://doi.org/10.1016/j.drudis.2020.07.007. DOI: https://doi.org/10.1016/j.drudis.2020.07.007
El Aita, I., Rahman, J., Breitkreutz, J., & Quodbach, J. (2020). 3D-Printing with precise layer-wise dose adjustments for paediatric use via pressure-assisted microsyringe printing. European Journal of Pharmaceutics and Biopharmaceutics, 157, 59-65. https://doi.org/10.1016/j.ejpb.2020.09.012. DOI: https://doi.org/10.1016/j.ejpb.2020.09.012
Fina, F., Goyanes, A., Gaisford, S., & Basit, A. W. (2017). Selective laser sintering (SLS) 3D printing of medicines. International journal of pharmaceutics, 529(1-2), 285-293. https://doi.org/10.1016/j.ijpharm.2017.06.082. DOI: https://doi.org/10.1016/j.ijpharm.2017.06.082
Glasgow, I. (2019). Cybersecurity for Medical Devices: Recommended Best Practices During Design, Development and Deployment. https://doi.org/10.4224/40000465.
Goh, O., Goh, W. J., Lim, S. H., Hoo, G. S., Liew, R., & Ng, T. M. (2022). Preferences of healthcare professionals on 3D-printed tablets: a pilot study. Pharmaceutics, 14(7), 1521. https://doi.org/10.3390/pharmaceutics14071521. DOI: https://doi.org/10.3390/pharmaceutics14071521
Goole, J., & Amighi, K. (2016). 3D printing in pharmaceutics: A new tool for designing customized drug delivery systems. International journal of pharmaceutics, 499(1-2), 376-394. https://doi.org/10.1016/j.ijpharm.2015.12.071. DOI: https://doi.org/10.1016/j.ijpharm.2015.12.071
Goyanes, A., Martinez, P. R., Buanz, A., Basit, A. W., & Gaisford, S. (2015). Effect of geometry on drug release from 3D printed tablets. International journal of pharmaceutics, 494(2), 657-663. https://doi.org/10.1016/j.ijpharm.2015.04.069. DOI: https://doi.org/10.1016/j.ijpharm.2015.04.069
Guidance, F. D. A. (2017). Technical Considerations for Additive Manufactured Medical Devices. Food and Drug Administration: New Hampshire, NH, USA.
Hurst, E. J. (2016). 3D printing in healthcare: emerging applications. Journal of Hospital Librarianship, 16(3), 255-267. https://doi.org/10.1080/15323269.2016.1188042. DOI: https://doi.org/10.1080/15323269.2016.1188042
Ilyés, K., Kovács, N. K., Balogh, A., Borbás, E., Farkas, B., Casian, T., ... & Nagy, Z. K. (2019). The applicability of pharmaceutical polymeric blends for the fused deposition modelling (FDM) 3D technique: Material considerations–printability–process modulation, with consecutive effects on in vitro release, stability and degradation. European Journal of Pharmaceutical Sciences, 129, 110-123. https://doi.org/10.1016/j.ejps.2018.12.019. DOI: https://doi.org/10.1016/j.ejps.2018.12.019
Jacobson, M. (2015). The regulatory and legal implications of 3D printing. MDT: Medical design technology.
Jackson, W. A., & Anderson, S. (2005). From electuaries to enteric coating: a brief history of dosage forms. Making Medicines: A Brief History of Pharmacy and Pharmaceuticals, 203.
Jamróz, W., Kurek, M., Łyszczarz, E., Szafraniec, J., Knapik-Kowalczuk, J., Syrek, K., ... & Jachowicz, R. (2017). 3D printed orodispersible films with Aripiprazole. International journal of pharmaceutics, 533(2), 413-420. https://doi.org/10.1016/j.ijpharm.2017.05.052. DOI: https://doi.org/10.1016/j.ijpharm.2017.05.052
Jewell, C., & Stones, J. (2018). 3D Printing Techniques in the Pharmaceutical Sciences–Intellectual Property Issues. 3D Printing of Pharmaceuticals, 183-213. https://doi.org/10.1007/978-3-319-90755-0_10. DOI: https://doi.org/10.1007/978-3-319-90755-0_10
Kadry, H., Wadnap, S., Xu, C., & Ahsan, F. (2019). Digital light processing (DLP) 3D-printing technology and photoreactive polymers in fabrication of modified-release tablets. European Journal of Pharmaceutical Sciences, 135, 60-67. https://doi.org/10.1016/j.ejps.2019.05.008. DOI: https://doi.org/10.1016/j.ejps.2019.05.008
Khairuzzaman, A. (2018). Regulatory perspectives on 3D printing in pharmaceuticals. 3D Printing of Pharmaceuticals, 215-236. https://doi.org/10.1007/978-3-319-90755-0_11. DOI: https://doi.org/10.1007/978-3-319-90755-0_11
Li, J., Chen, M., Fan, X., & Zhou, H. (2016). Recent advances in bioprinting techniques: approaches, applications and future prospects. Journal of translational medicine, 14, 1-15. https://doi.org/10.1186/s12967-016-1028-0. DOI: https://doi.org/10.1186/s12967-016-1028-0
Musazzi, U. M., Khalid, G. M., Selmin, F., Minghetti, P., & Cilurzo, F. (2020). Trends in the production methods of orodispersible films. International journal of pharmaceutics, 576, 118963. https://doi.org/10.1016/j.ijpharm.2019.118963. DOI: https://doi.org/10.1016/j.ijpharm.2019.118963
Norman, J., Madurawe, R. D., Moore, C. M., Khan, M. A., & Khairuzzaman, A. (2017). A new chapter in pharmaceutical manufacturing: 3D-printed drug products. Advanced drug delivery reviews, 108, 39-50. https://doi.org/10.1016/j.addr.2016.03.001. DOI: https://doi.org/10.1016/j.addr.2016.03.001
Palo, M., Holländer, J., Suominen, J., Yliruusi, J., & Sandler, N. (2017). 3D printed drug delivery devices: perspectives and technical challenges. Expert review of medical devices, 14(9), 685-696. https://doi.org/10.1080/17434440.2017.1363647. DOI: https://doi.org/10.1080/17434440.2017.1363647
Parulski, C., Jennotte, O., Lechanteur, A., & Evrard, B. (2021). Challenges of fused deposition modeling 3D printing in pharmaceutical applications: where are we now?. Advanced drug delivery reviews, 175, 113810. https://doi.org/10.1016/j.addr.2021.05.020. DOI: https://doi.org/10.1016/j.addr.2021.05.020
Sen, K., Mehta, T., Sansare, S., Sharifi, L., Ma, A. W., & Chaudhuri, B. (2021). Pharmaceutical applications of powder-based binder jet 3D printing process–a review. Advanced Drug Delivery Reviews, 177, 113943. https://doi.org/10.1016/j.addr.2021.113943. DOI: https://doi.org/10.1016/j.addr.2021.113943
Trenfield, S. J., Madla, C. M., Basit, A. W., & Gaisford, S. (2018). Binder jet printing in pharmaceutical manufacturing. 3D printing of pharmaceuticals, 41-54. https://doi.org/10.1007/978-3-319-90755-0_3. DOI: https://doi.org/10.1007/978-3-319-90755-0_3
Wang, J., Goyanes, A., Gaisford, S., & Basit, A. W. (2016). Stereolithographic (SLA) 3D printing of oral modified-release dosage forms. International journal of pharmaceutics, 503(1-2), 207-212. https://doi.org/10.1016/j.ijpharm.2016.03.016. DOI: https://doi.org/10.1016/j.ijpharm.2016.03.016
West, T. G., & Bradbury, T. J. (2019). 3D printing: a case of ZipDose® technology–world's first 3D printing platform to obtain FDA approval for a pharmaceutical product. 3D and 4D Printing in Biomedical Applications: Process Engineering and Additive Manufacturing, 53-79. https://doi.org/10.1002/9783527813704.ch3. DOI: https://doi.org/10.1002/9783527813704.ch3
Publicado
Edição
Seção
Licença
Copyright (c) 2024 Revista Sociedade Científica
Este trabalho está licenciado sob uma licença Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
